AABB is instrumental in making biotherapies safe, effective and available worldwide.
The AABB biotherapies community is transforming patient care. We are driving policies to ensure patient access, expanding coverage for transformative therapies, advancing novel biotherapies research, and increasing the supply and safety of biological products. Together, this community is leading the discovery, development and delivery of innovative outcomes.
AABB represents expertise in quality management systems relevant to biotherapies. These efforts include consensus-based standards, accreditation, and novel qualification products.
AABB leads a wide range of professional development approaches designed to help members and the biotherapies community extend their knowledge and further their careers. Certification in Advanced Biotherapies represents significant achievement as a biotherapies professional.
Certification in Advanced Biotherapies
AABB provides current information, resources and interpretive guidance for biotherapies professionals, patients and regulators. These efforts improve patient access and coordination of the field worldwide.
AABB supports a wide-range of innovative projects fueled by expert membership, partnerships and industry leadership engagement and recognition.
Biotherapies use cells, living (bio) organisms, components of living organisms, substances derived from organisms, or laboratory-made versions of those substances to improve health, treat illness, or disease.
Biotherapies can be organized in a few general categories, though continued research and clinical studies will likely lead to future expansion and further innovative applications.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977